Folate status in women of reproductive age as basis of neural tube defect risk assessment

Annals of the New York Academy of Sciences

Volumn 1414, Issue 1, 2018, Pages 82-95

  Bailey, Lynn B ^a   Hausman, Dorothy B ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

global; NTD risk; RBC folate; reproductive age; women

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

ARTICLE; CLINICAL TRIAL; ERYTHROCYTE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GUATEMALA; HUMAN; KNOWLEDGE; MICROBIOLOGY; NEURAL TUBE DEFECT; RISK ASSESSMENT; RISK REDUCTION; VITAMIN SUPPLEMENTATION;

EID: 85034243000     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13511     Document Type: Article

References (67)

1. Word Health Organization. 2015. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization
2. Pfeiffer, C.M., M. Zhang, D.A. Lacher, et al. 2011. Comparison of serum and red blood cell folate microbiologic assays for national population surveys. J. Nutr. 141: 1402–1409
3. Pfeiffer, C.M., M. Zhang & S. Jabbar. 2018. Framework for laboratory harmonization of folate measurements in low- and middle-income countries and regions. Ann. N.Y. Acad. Sci. 1414: 96–108
4. World Health Organization. 2015. Serum and red blood cell folate concentrations for assessing folate status in populations. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization
5. Bailey, L.B., P.J. Stover, H. McNulty, et al. 2015. Biomarkers of nutrition for development—folate review. J. Nutr. 145: 1636S–1680S
6. Bailey, L. & M. Caudill. 2012. Folate. In Present Knowledge in Nutrition. 10th ed. J. Erdman, I. MacDonald & S. Zeisel, Eds.: 321–342. Hoboken, NJ: Wiley-Blackwell
7. Hao, L., J. Ma, M.J. Stampfer, et al. 2003. Geographical, seasonal and gender differences in folate status among Chinese adults. J. Nutr. 133: 3630–3635
8. Pfeiffer, C.M., J.P. Hughes, D.A. Lacher, et al. 2012. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988–2010. J. Nutr. 142: 886–893
9. Yang, Q., M.E. Cogswell, H.C. Hamner, et al. 2010. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am. J. Clin. Nutr. 91: 64–72
10. Berry, R.J., Z. Li, J.D. Erickson, et al. 1999. Prevention of neural-tube defects with folic acid in China. China–U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 341: 1485–1490
11. Yeung, L., Q. Yang & R.J. Berry. 2008. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 300: 2486–2487
12. Hertrampf, E., F. Cortés, J.D. Erickson, et al. 2003. Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile. J. Nutr. 133: 3166–3169
13. Hopkins, S.M., M.J. Gibney, A.P. Nugent, et al. 2015. Impact of voluntary fortification and supplement use on dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults. Am. J. Clin. Nutr. 101: 1163–1172
14. Caudill, M.A., A.C. Cruz, J.F. Gregory, et al. 1997. Folate status response to controlled folate intake in pregnant women. J. Nutr. 127: 2363–2370
15. Hao, L., Q.H. Yang, Z. Li, et al. 2008. Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am. J. Clin. Nutr. 88: 448–457
16. Tighe, P., M. Ward, H. McNulty, et al. 2011. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am. J. Clin. Nutr. 93: 11–18
17. Duffy, M.E., L. Hoey, C.F. Hughes, et al. 2014. Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 99: 96–106
18. Wright, A.J., M.J. King, C.A. Wolfe, et al. 2010. Comparison of (6 S)-5-methyltetrahydrofolic acid v. folic acid as the reference folate in longer-term human dietary intervention studies assessing the relative bioavailability of natural food folates: comparative changes in folate status following a 16-week placebo-controlled study in healthy adults. Br. J. Nutr. 103: 724–729
19. Pfeiffer, C.M., M.R. Sternberg, H.C. Hamner, et al. 2016. Applying inappropriate cutoffs leads to misinterpretation of folate status in the US population. Am. J. Clin. Nutr. 104: 1607–1615
20. Daly, L.E., P.N. Kirke, A. Molloy, et al. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702
21. Crider, K.S., O. Devine, L. Hao, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349: g4554
22. Shane, B. 2010. Folate chemistry and metabolism. In Folate in Health and Disease. 2nd ed. L. Bailey, Ed.: 1–24. Boca Raton, FL: CRC Press, Taylor Francis Group
23. Mason, J.B. 2003. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J. Nutr. 133(Suppl. 3): 941S–947S
24. Clifford, A.J., E.M. Noceti, A. Block-Joy, et al. 2005. Erythrocyte folate and its response to folic acid supplementation is assay dependent in women. J. Nutr. 135: 137–143
25. Houghton, L.A., A.R. Gray, M.C. Rose, et al. 2011. Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects. Am. J. Clin. Nutr. 94: 136–141
26. Wu, A., I. Chanarin, G. Slavin & A.J. Levi. 1975. Folate deficiency in the alcoholic—its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br. J. Haematol. 29: 469–478
27. Rosenthal, J., N. Largaespada, L.B. Bailey, et al. 2017. Folate deficiency is prevalent in women of childbearing age in Belize and is negatively affected by coexisting vitamin B-12 deficiency: Belize National Micronutrient Survey 2011. J. Nutr. 147: 1183–1193
28. Molloy, A.M., P.N. Kirke, J.F. Troendle, et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123: 917–923
29. 12 status be considered in assessing risk of neural tube defects? Ann. N.Y. Acad. Sci. 1414: 109–125
30. Clarke, R., D.A. Bennett, S. Parish, et al. 2012. Homocysteine and coronary heart disease: meta-analysis of MTHFR case–control studies, avoiding publication bias. PLoS Med. 9: e1001177
31. Yang, Q.H., L.D. Botto, M. Gallagher, et al. 2008. Prevalence and effects of gene–gene and gene–nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am. J. Clin. Nutr. 88: 232–246
32. Crider, K.S., J.H. Zhu, L. Hao, et al. 2001. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am. J. Clin. Nutr. 93: 1365–1372
33. Yan, L., L. Zhao, Y. Long, et al. 2012. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case–control studies. PLoS One 7: e41689
34. Zhang, T, J. Lou, R. Zhong, et al. 2013. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One 8: e59570
35. Metz, J. 2007. Folic acid metabolism and malaria. Food Nutr. Bull. 28(4 Suppl.): S540–S549
36. Nzila, A., J. Okombo & A.M. Molloy. 2014. Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate. J. Antimicrob. Chemother. 69: 323–330
37. Gregson, A. & C.V. Plowe. 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57: 117–145
38. Oppenheimer, S.J. & P. Cashin. 1986. Serum and red cell folate levels associated with malarial parasitaemia. Trans. R. Soc. Trop. Med. Hyg. 80: 169–171
39. Chango, A. & L. Abdennebi-Najar. 2011. Folate metabolism pathway and Plasmodium falciparum malaria infection in pregnancy. Nutr. Rev. 69: 34–40
40. Mazumdar, M., M.O. Ibne Hasan, R. Hamid, et al. 2015. Arsenic is associated with reduced effect of folic acid in myelomeningocele prevention: a case control study in Bangladesh. Environ. Health 14: 34
41. Kamynina, E., E.R. Lachenauer, A.C. DiRisio, et al. 2017. Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis. Proc. Natl. Acad. Sci. USA 114: E2319–E2326
42. Howe, C.G., M.M. Niedzwiecki, M.N. Hall, et al. 2014. Folate and cobalamin modify associations between S-adenosylmethionine and methylated arsenic metabolites in arsenic-exposed Bangladeshi adults. J. Nutr. 144: 690–697
43. Hall, M.N. & M.V. Gamble. 2012. Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J. Toxicol. 2012: 595307
44. Pfeiffer, C.M., M.R. Sternberg, R.L. Schleicher & M.E. Rybak. 2012. Dietary supplement use and smoking are important correlates of biomarkers of water-soluble vitamin status after adjusting for sociodemographic and lifestyle variables in a representative sample of U.S. adults. J. Nutr. 143: 957S–965S
45. Rosenthal, J., M.E. Reeve, N. Ramirez, et al. 2016. Red blood cell folate insufficiency among nonpregnant women of childbearing age in Guatemala 2009 to 2010: prevalence and predicted neural tube defects risk. Birth Defects Res. A Clin. Mol. Teratol. 106: 587–595
46. Branum, A.M., R. Bailey & B.J. Singer. 2013. Dietary supplement use and folate status during pregnancy in the United States. J. Nutr. 143: 486–492
47. Parker, S.E., C.T. Mai, M.A. Canfield, et al. 2010. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res. A Clin. Mol. Teratol. 88: 1008–1016
48. Centers for Disease Control and Prevention. 2010. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb. Mortal. Wkly. Rep. 59: 980–984
49. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131–137
50. Czeizel, A.E. & I. Dudás. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327: 1832–1835
51. Cortés, F., C. Mellado, R.A. Pardo, et al. 2012. Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am. J. Med. Genet. A 158A: 1885–1890
52. De Wals, P., F. Tairou, M.I. Van Allen, et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 357: 135–142
53. De Wals, P., F. Tairou, M.I. Van Allen, et al. 2008. Spina bifida before and after folic acid fortification in Canada. Birth Defects Res. A Clin. Mol. Teratol. 82: 622–626
54. Chen, L.T. & M.A. Rivera. 2004. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr. Rev. 62(6 Pt 2): S40–S43
55. Williams, L.J., C.T. Mai, L.D. Edmonds, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33–39
56. Sayed, A.R., D. Bourne, R. Pattinson, et al. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost–benefit in South Africa. Birth Defects Res. A Clin. Mol. Teratol. 82: 211–216
57. Center for Disease Control. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 41: 1–7
58. Tinker, S.C., H.C. Hamner, Y.P. Qi & K.S. Crider. 2015. U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012. Birth Defects Res. A Clin. Mol. Teratol. 103: 517–526
59. Molloy, A.M. & J.M. Scott. 1997. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol. 281: 43–53
60. Serdula, M.K., E.K. Nichols, N.J. Aburto, et al. 2014. Micronutrient status in Jordan: 2002 and 2010. Eur. J. Clin. Nutr. 68: 1124–1128
61. Labadarios, D., R. Swart, E. Maunder, et al. 2008. Executive summary of the National Food Consumption Survey Fortification Baseline (NFCS-FB-I). S. Afr. J. Clin. Nutr. 21(Suppl. 2): 247–300
62. Freire, W., M. Ramirez-Luzuriaga, P. Belmont, et al. 2014. Tomo I: Encuesta Nacional de Salud y Nutrición de la población ecuatoriana de cero a 59 años. ENSANUT-ECU 2012. Ministry of Public Health/National Institute of Statistics and Census, Quito
63. Rosenthal, J., E. Lopez-Pazos, N.F. Dowling, et al. 2015. Folate and vitamin B12 deficiency among non-pregnant women of childbearing-age in Guatemala 2009–2010: prevalence and identification of vulnerable populations. Matern. Child Health J. 19: 2272–2285
64. Imhoff-Kunsch, B., R. Flores, O. Dary & R. Martorell. 2007. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J. Nutr. 137: 1017–1022
65. Garrett, G.S. & L.B. Bailey. 2018. A public health approach for preventing neural tube defects: folic acid fortification and beyond. Ann. N.Y. Acad. Sci. 1414: 47–58
66. McLean, E., B. de Benoist & L.H. Allen. 2008. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr. Bull. 29(Suppl. 2): S38–S51
67. Institute of Medicine. 1998. DRI dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press